USD 2.14
(-12.14%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 72.53 Million CAD | 3.79% |
2022 | 69.88 Million CAD | 26.08% |
2021 | 55.42 Million CAD | 18.02% |
2020 | 46.96 Million CAD | 95.57% |
2019 | 24.01 Million CAD | 40182.48% |
2018 | 59.61 Thousand CAD | -91.03% |
2017 | 664.67 Thousand CAD | -96.53% |
2016 | 19.16 Million CAD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q3 | 66.42 Million CAD | -1.78% |
2024 Q1 | 65.31 Million CAD | -9.95% |
2024 Q2 | 67.62 Million CAD | 3.55% |
2023 Q4 | 72.53 Million CAD | 4.17% |
2023 Q1 | 68.4 Million CAD | -2.12% |
2023 FY | 72.53 Million CAD | 3.79% |
2023 Q2 | 70.29 Million CAD | 2.76% |
2023 Q3 | 69.62 Million CAD | -0.95% |
2022 Q3 | 63.18 Million CAD | 3.86% |
2022 Q1 | 58.16 Million CAD | 4.94% |
2022 FY | 69.88 Million CAD | 26.08% |
2022 Q4 | 69.88 Million CAD | 10.6% |
2022 Q2 | 60.84 Million CAD | 4.6% |
2021 Q1 | 84.56 Million CAD | 80.06% |
2021 FY | 55.42 Million CAD | 18.02% |
2021 Q3 | 52.74 Million CAD | -4.64% |
2021 Q4 | 55.42 Million CAD | 5.08% |
2021 Q2 | 55.31 Million CAD | -34.59% |
2020 Q3 | 48.88 Million CAD | -1.93% |
2020 FY | 46.96 Million CAD | 95.57% |
2020 Q4 | 46.96 Million CAD | -3.93% |
2020 Q2 | 49.84 Million CAD | 2.47% |
2020 Q1 | 48.64 Million CAD | 102.57% |
2019 FY | 24.01 Million CAD | 40182.48% |
2019 Q1 | 10.37 Million CAD | 17307.06% |
2019 Q4 | 24.01 Million CAD | 1.0% |
2019 Q3 | 23.77 Million CAD | 29.22% |
2019 Q2 | 18.4 Million CAD | 77.31% |
2018 Q3 | - CAD | 0.0% |
2018 FY | 59.61 Thousand CAD | -91.03% |
2018 Q4 | 59.61 Thousand CAD | 0.0% |
2018 Q1 | - CAD | -100.0% |
2017 Q4 | 19.26 Million CAD | 0.0% |
2017 FY | 664.67 Thousand CAD | -96.53% |
2016 FY | 19.16 Million CAD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
CannBioRx Life Sciences Corp. | 1.32 Million USD | -5394.41% |
BIMI International Medical Inc. | 5.45 Million USD | -1229.523% |
China Jo-Jo Drugstores, Inc. | 43.21 Million USD | -67.816% |
Harrow Health, Inc. 8.625% Senior Notes due 2026 | 190.5 Million USD | 61.927% |
Harrow Health, Inc. 11.875% Senior Notes due 2027 | 183.17 Million USD | 60.403% |
Leafly Holdings, Inc. | 29.08 Million USD | -149.373% |
Leafly Holdings, Inc. | 29.08 Million USD | -149.373% |
LifeMD, Inc. | 18.93 Million USD | -283.101% |
LifeMD, Inc. | 18.93 Million USD | -283.101% |
TRxADE HEALTH, Inc. | 7.1 Million USD | -920.987% |
PetMed Express, Inc. | 1.45 Million USD | -4888.308% |
Walgreens Boots Alliance, Inc. | 9.55 Billion USD | 99.241% |